Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cyber warning letters

This article was originally published in The Tan Sheet

Executive Summary

FDA has issued several "cyber" letters to Internet dietary supplement marketers for promoting products with improper claims. Cosmeceutical Technologies received a letter from the agency stating that its HoodiThin weight-loss supplement carried inappropriate drug claims on the firm's promotional website. Physician Formulas also made drug claims for its Serrapeptase anti-inflammatory, 5-HTP anti-depressant and Prostate Power Rx supplements, according to a separate FDA letter. Additionally, FDA sent a follow-up letter to Torica Productions concerning statements made for its product The Greatest Vitamin in the World that the agency cited in a letter sent last July. The agency particularly objected to claims and testimonials touting the product's benefits for conditions such as diabetes, stroke, heart disease, insomnia, cancer and arthritis, which would require the product to be regulated as a drug...

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts